Genzyme Closes Sale of Diagnostic Products Unit

In CategoryBusiness, Products, Health Dangers, Etc
ByRuss Bianchi

Genzyme Corp. said Feb. 1 it completed the sale of its diagnostic products business to Sekisui Chemical Co. Ltd. for $265 million in cash.

Genzyme Closes Sale of Diagnostic Products Unit

Share

Tags: ,

Comments are closed.